Dr. Jack Cush reviews the news from the past week on RheumNow.com, including news on inappropriate opioids, pre-clinical RA treatment, DMARDs in Gout, the decline of arthroscopy and a pain in the mouth.
The American College of Rheumatology (ACR) today released the Rheumatic Disease Report Card: Raising the Grade on Rheumatology Care in America, a first-of-its-kind report that evaluates just how difficult it can be to live well with a rheumatic disease in the United States.
The British Society of Rheumatology has produced a set of NICE accredited guidelines for the use of biologic therapies in patients with inflammatory arthritis.
Pregnancy and drug safety is a complex issue, often with limited informatoin about maternal drug exposure on the offspring. Greater uncertainty exists when considering whether paternal exposure may also influence fetal outcomes.
The current issue of the CDC's MMWR reviews the new seasonal recommendations for vaccination against influenza. This is an update to the previous recommendations of the Advisory Committee on Immunization Practices (ACIP).
Yesterday, the American College of Rheumatology (ACR) met with U.S.
A Danish population study suggests that fetal exposure to maternal rheumatoid arthritis (RA) results in an increased offspring risk of thyroid disease, epilepsy and RA, compared to children born to mothers without RA.
Interleukin-1 (IL-1) suppression helped reverse symptoms of dilated cardiomyopathy (DCM) for one patient in a case study that may implicate inflammation in the development of the condition.
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.
Dr. Jack Cush reviews highlights from the news and social media on RheumNow.com in the past week.
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com. Fateful outcomes in Rheumatology, what happens to Seronegatives, IL-23 fails, MRI progression, Not all inflammatory back pain becomes SpA:
Hydroxychloroquine (HCQ) retinopathy prevention guidelines have revised from ideal body weight (IBW)-based dosing to actual body weight (ABW)-based dosing; the question remains whether these have been adopted in clinical practice.
alexa meara @lexmeara ( View Tweet )
Robert B Chao, MD @doctorRBC ( View Tweet )
Mrinalini Dey @DrMiniDey ( View Tweet )
Links:
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
